Tag Archive for: lutetium Lu 177 dotatate

FDA approved lutetium Lu 177 dotatate for the treatment of somatostatin receptor-positive GEP-NETs

/0 Comments/in , /by

 

  • FDA approved lutetium Lu 177 dotatate (LUTATHERA, Advanced Accelerator Applications USA, Inc.) a radiolabeled somatostatin analogue, for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours (GEP-NETs), including foregut, midgut, and hindgut neuroendocrine tumours in adults. More Information.